Dalpiciclib
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study (NCT07581834) | Fujian Cancer Hospital | 2026-01-21 |
Track Dalpiciclib automatically
Every clearance here is in the API, with alerts when new ones post.